opportunities

Drug discovery success stories from our in-house projects – options for partnering

February 26, 2021

Selective Antagonists of the A2B Adenosine Receptor

Using X-ray structure-based molecular design, leadXpro has discovered, optimised and patented two new series of selective antagonists of the A2B adenosine receptor.